Lubner David Charles

Lubner David Charles is listed in filings as Director at Arcellx, Inc.. This profile follows SEC Form 4 activity through Apr 28, 2026, including sale activity. Recent filings connect the profile to Arcellx, Inc. (ACLX), Dyne Therapeutics, Inc. (DYN), CARGO Therapeutics, Inc. Common Stock (CRGX), and Vor Biopharma Inc. (VOR). The current snapshot covers public activity from May 23, 2025 to Apr 28, 2026. Reported amounts are shown as $2.5M to $584.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.